About: Swiss HIV Cohort Study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Swiss HIV Cohort Study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

organization in Zurich, Switzerland

Attributes	Values
rdf:type	Item
description	Schweizer Organisation (de) organisatie uit Zwitserland (nl) منظمة في زيورخ، سويسرا (ar) organization in Zurich, Switzerland (en)
rdfs:label	Swiss HIV Cohort Study (en)
skos:prefLabel	Swiss HIV Cohort Study (en)
name	Swiss HIV Cohort Study (en)
ROR ID	wds:Q33121558-2984F8FC-63C0-4FF4-961F-480912CADB77
ROR ID	048hyya13
Gateway to Research organisation ID	wds:Q33121558-9115FA4B-D9E1-4C1D-BCA6-199A871979C8
Gateway to Research organisation ID	418620C5-9575-4FF6-9E94-332A4252B284
instance of	wds:Q33121558-EF525F66-BA1F-4EC5-96BD-5E263BDBB43C
instance of	organization
country	wds:Q33121558-0D7C831A-F924-47AC-B30A-33E50BFFD820
country	Switzerland
inception	wds:Q33121558-EF8DA824-AAC3-4F07-A8F9-0F9AD1B1E746
inception	1988-01-01 00:00:00Z (xsd:dateTime)
skos:altLabel	SHCS (en)
located in the adm...erritorial entity	wds:Q33121558-C0B67575-7388-4898-9B33-9E9AE5A12C1C
coordinate location	wds:Q33121558-E495B048-25CD-4C6A-96B0-04CE587E492C
official website	wds:Q33121558-EFA9DDA3-81AF-445E-B487-721017BD98E1
located in the adm...erritorial entity	Zürich
coordinate location	POINT(8.551071 47.376748)
official website	http://www.shcs.ch/
GRID ID	wds:Q33121558-92492274-797B-4CE1-9D6C-50E2C1DA99E7
GRID ID	grid.483654.8
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q33121558
is author of	Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study. Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions Factors Associated with the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS). Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point. Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients HIV-1 co/super-infection in intravenous drug users Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial. Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection Impact of highly active antiretroviral therapy on the molecular epidemiology of newly diagnosed HIV infections Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir Migrants from sub-Saharan Africa in the Swiss HIV Cohort Study: a single center study of epidemiologic migration-specific and clinical features Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B. A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA. HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy. A smoking cessation programme in HIV-infected individuals: a pilot study. JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study. Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 × 106/l Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts. Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients HIV-1-infected patients with focal neurologic signs: diagnostic role of PCR for Toxoplasma gondii, Epstein-Barr virus, and JC virus Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study Cohort profile: the Swiss HIV Cohort study. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infection. Productivity costs and determinants of productivity in HIV-infected patients. A longitudinal analysis of healthcare costs after treatment optimization following genotypic antiretroviral resistance testing: does resistance testing pay off? Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection Parents living with HIV in a high-income country: do patients need specific support? Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software